Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Parathyroid Disorders Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Simple Parathyroid Disorders
  • 1.4.3 Complex Parathyroid Disorders
• 1.5 Market by Application
  • 1.5.1 Global Parathyroid Disorders Market Share by Application (2014-2025)
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Diagnostic Centers
  • 1.5.5 Drug Stores
  • 1.5.6 Pharmacies
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Parathyroid Disorders Market Size
• 2.2 Parathyroid Disorders Growth Trends by Regions
  • 2.2.1 Parathyroid Disorders Market Size by Regions (2014-2025)
  • 2.2.2 Parathyroid Disorders Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Parathyroid Disorders Market Size by Manufacturers
  • 3.1.1 Global Parathyroid Disorders Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Parathyroid Disorders Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Parathyroid Disorders Market Concentration Ratio (CR5 and HHI)
• 3.2 Parathyroid Disorders Key Players Head office and Area Served
• 3.3 Key Players Parathyroid Disorders Product/Solution/Service
• 3.4 Date of Enter into Parathyroid Disorders Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Parathyroid Disorders Market Size by Type (2014-2019)
• 4.2 Global Parathyroid Disorders Market Size by Application (2014-2019)

5 United States

• 5.1 United States Parathyroid Disorders Market Size (2014-2019)
• 5.2 Parathyroid Disorders Key Players in United States
• 5.3 United States Parathyroid Disorders Market Size by Type
• 5.4 United States Parathyroid Disorders Market Size by Application

6 Europe

• 6.1 Europe Parathyroid Disorders Market Size (2014-2019)
• 6.2 Parathyroid Disorders Key Players in Europe
• 6.3 Europe Parathyroid Disorders Market Size by Type
• 6.4 Europe Parathyroid Disorders Market Size by Application

7 China

• 7.1 China Parathyroid Disorders Market Size (2014-2019)
• 7.2 Parathyroid Disorders Key Players in China
• 7.3 China Parathyroid Disorders Market Size by Type
• 7.4 China Parathyroid Disorders Market Size by Application

8 Japan

• 8.1 Japan Parathyroid Disorders Market Size (2014-2019)
• 8.2 Parathyroid Disorders Key Players in Japan
• 8.3 Japan Parathyroid Disorders Market Size by Type
• 8.4 Japan Parathyroid Disorders Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Parathyroid Disorders Market Size (2014-2019)
• 9.2 Parathyroid Disorders Key Players in Southeast Asia
• 9.3 Southeast Asia Parathyroid Disorders Market Size by Type
• 9.4 Southeast Asia Parathyroid Disorders Market Size by Application

10 India

• 10.1 India Parathyroid Disorders Market Size (2014-2019)
• 10.2 Parathyroid Disorders Key Players in India
• 10.3 India Parathyroid Disorders Market Size by Type
• 10.4 India Parathyroid Disorders Market Size by Application

11 Central & South America

• 11.1 Central & South America Parathyroid Disorders Market Size (2014-2019)
• 11.2 Parathyroid Disorders Key Players in Central & South America
• 11.3 Central & South America Parathyroid Disorders Market Size by Type
• 11.4 Central & South America Parathyroid Disorders Market Size by Application

12 International Players Profiles

• 12.1 Abbott Laboratories
  • 12.1.1 Abbott Laboratories Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Parathyroid Disorders Introduction
  • 12.1.4 Abbott Laboratories Revenue in Parathyroid Disorders Business (2014-2019)
  • 12.1.5 Abbott Laboratories Recent Development
• 12.2 Alcon Laboratories
  • 12.2.1 Alcon Laboratories Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Parathyroid Disorders Introduction
  • 12.2.4 Alcon Laboratories Revenue in Parathyroid Disorders Business (2014-2019)
  • 12.2.5 Alcon Laboratories Recent Development
• 12.3 Amgen
  • 12.3.1 Amgen Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Parathyroid Disorders Introduction
  • 12.3.4 Amgen Revenue in Parathyroid Disorders Business (2014-2019)
  • 12.3.5 Amgen Recent Development
• 12.4 Bayer Healthcare
  • 12.4.1 Bayer Healthcare Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Parathyroid Disorders Introduction
  • 12.4.4 Bayer Healthcare Revenue in Parathyroid Disorders Business (2014-2019)
  • 12.4.5 Bayer Healthcare Recent Development
• 12.5 Becton, Dickinson and Company
  • 12.5.1 Becton, Dickinson and Company Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Parathyroid Disorders Introduction
  • 12.5.4 Becton, Dickinson and Company Revenue in Parathyroid Disorders Business (2014-2019)
  • 12.5.5 Becton, Dickinson and Company Recent Development
• 12.6 Eli Lilly
  • 12.6.1 Eli Lilly Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Parathyroid Disorders Introduction
  • 12.6.4 Eli Lilly Revenue in Parathyroid Disorders Business (2014-2019)
  • 12.6.5 Eli Lilly Recent Development
• 12.7 Ethicon
  • 12.7.1 Ethicon Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Parathyroid Disorders Introduction
  • 12.7.4 Ethicon Revenue in Parathyroid Disorders Business (2014-2019)
  • 12.7.5 Ethicon Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Parathyroid disorders lead to abnormal levels of calcium in the blood that can cause brittle bones, kidney stones, fatigue, weakness, and other problems.
Patients with chronic kidney disease may develop secondary hyperparathyroidism with resultant chronic kidney disease-mineral and bone disorder. Hypoparathyroidism most often occurs after neck surgery; it can also be caused by autoimmune destruction of the glands and other less common problems. Evaluation of patients with abnormal serum calcium levels includes a history and physical examination; repeat measurement of serum calcium level; and measurement of creatinine, magnesium, vitamin D, and parathyroid hormone levels. The treatment for symptomatic primary hyperparathyroidism is parathyroidectomy. Management of asymptomatic primary hyperparathyroidism includes monitoring symptoms; serum calcium and creatinine levels; and bone mineral density. Patients with hypoparathyroidism require close monitoring and vitamin D (e.g., calcitriol) replacement.
In 2018, the global Parathyroid Disorders market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Parathyroid Disorders status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Parathyroid Disorders development in United States, Europe and China.

The key players covered in this study
Abbott Laboratories
Alcon Laboratories
Amgen
Bayer Healthcare
Becton, Dickinson and Company
Eli Lilly
Ethicon
...

Market segment by Type, the product can be split into
Simple Parathyroid Disorders
Complex Parathyroid Disorders

Market segment by Application, split into
Hospitals
Clinics
Diagnostic Centers
Drug Stores
Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Parathyroid Disorders status, future forecast, growth opportunity, key market and key players.
To present the Parathyroid Disorders development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Parathyroid Disorders are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.